N/A
N=402
EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT03308188 ↗Enrolled (actual)
402
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Decrease in Morphine Equivalent Dose (MED) — 85; 105 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- E-health program (Behavioral)
- Age
- Adult, Older Adult · 25+ yrs
- Sex
- All
- Sponsor
- University of Cincinnati
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Decrease in Morphine Equivalent Dose (MED) |
85; 105 | — |
| SECONDARY Pain Intensity |
13; 24 | — |
Summary
This is a 10-month internet-based randomized controlled trial to evaluate whether an online chronic pain management program ("E-Health") can assist with reduced opioid reliance in chronic pain patients. About half of the eligible participants will receive access to the E-Health program in addition to their standard chronic pain treatment; the other half will just continue receiving their standard chronic pain treatment.
Eligibility Criteria
Inclusion Criteria
- Be 25-80 years of age
- Be able to understand the study, and having understood, provide informed consent in English
- Have a daily average prescribed MED ≥ 20 mg over a recent three-month period
- Have a chronic pain-related diagnosis
- Self-report current use of opioid medication(s) to treat pain
- Have a Brief Pain Inventory Pain Intensity score ≥3
- Have internet access and a working email account
Exclusion Criteria
- Be anyone who, in the judgment of study staff, would be unlikely to complete the study (e.g., planning to change to a different primary care clinic, have a terminal illness, etc.)
- Be unwilling/unable to complete the WebNeuro assessments
- Be pregnant
- Be a prisoner
Data sourced from ClinicalTrials.gov (NCT03308188). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.